Suzuki K, Yasui Y, Tsuchiya K, Matsumoto H, et al. Impact of immune-related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. J Gastroenterol Hepatol 2024 Mar 17. doi: 10.1111/jgh.16532.
PMID: 38494668